Faron Pharmaceuticals Ltd: Holding(s) in Company

About this update from Faron Pharmaceuticals Oy

[{"type":"text","content":"TURKU, FINLAND / ACCESS Newswire / December 4, 2025 / Faron Pharmaceuticals (HEL:FARON)(LSE:FARN) | Company announcement | December 04, 2025 at 18:00:00 EET","length":156,"tagName":"p"},{"type":"text","content":"TR-1: Standard form for notification of major holdings","length":54,"tagName":"p"},{"type":"table","headerItems":[],"items":[{"val":[{"colspan":"7","rowspan":"1","style":"border:1px solid black;padding:2px 4px;","val":[{"type":"text","content":"NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i","length":120,"tagName":"p"}]}]},{"val":[{"colspan":"7","rowspan":"1","style":"border-bottom-color:black;border-bottom-style:solid;border-left-color:#DDDDDD;border-left-style:none;border-right-color:#DDDDDD;border-right-style:none;border-top-color:black;border-top-style:solid;border-width:1px;padding:2px 4px;text-align:right;","val":[]}]},{"val":[{"colspan":"3","rowspan":"1","style":"border:1px solid black;padding:2px 4px;","val":[{"type":"text","content":"1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii:","length":110,"tagName":"p"}]},{"colspan":"4","rowspan":"1","style":"border:1px solid black;padding:2px 4px;text-align:center;","val":[{"type":"text","content":"Faron Pharmaceuticals Ltd","length":25,"tagName":"p"}]}]},{"val":[{"colspan":"7","rowspan":"1","style":"border:1px solid black;padding:2px 4px;","val":[{"type":"text","content":"1b. Please indicate if the issuer is a non-UK issuer (please mark with an "X" if appropriate)","length":103,"tagName":"p"}]}]},{"val":[{"colspan":"6","rowspan":"1","style":"border:1px solid black;padding:2px 4px;","val":[{"type":"text","content":"Non-UK issuer","length":13,"tagName":"p"}]},{"colspan":"1","rowspan":"1","style":"border:1px solid black;padding:2px 4px;text-align:center;","val":[{"type":"text","content":"X","length":1,"tagName":"p"}]}]},{"val":[{"colspan":"7","rowspan":"1","style":"border:1px solid black;padding:2px 4px;","val":[{"type":"text","content":"2. Reason for the notification (please mark the appropriate box or boxes with an "X")","length":95,"tagName":"p"}]}]},{"val":[{"colspan":"6","rowspan":"1","style":"border:1px solid black;padding:2px 4px;","val":[{"type":"text","content":"An acquisition or disposal of voting rights","len...

More updates from Faron Pharmaceuticals Oy